CCR5 and acute lymphoblastic leukemia: Subgroup analyses revealed that the effect of gender was not significantly different among CCR5 genotypes (female ALL versus female control, OR = 0.52; 95%CI = 0.09–3.07, and male ALL versus male control, OR = 0.97; 95%CI = 0.18–5.14).